Abstract: The aim of this study was to develop experimental titanium implants sputter-coated from a hydroxyapatite target and to evaluate peri-implant tissue responses in an animal experiment. The experimental implants were prepared from plastic rods, each of which was 1.6 mm in diameter and 7 mm in length. A thin titanium film was deposited onto the rods by DC magnetron sputtering. The surface of each rod was subsequently sputter-coated from a hydroxyapatite target by RF magnetron sputtering. The experimental implants were placed in the tibiae of 8-week-old male SD rats. Titanium-coated implants were placed as controls using the same method. Tissue samples were obtained 3, 5, 7, 10, 14, and 28 days after implant placement. Histological evaluation was performed using a light microscope, and the bone-implant contact ratios (BICs) were measured. Microstructural observations of implant-bone interfaces were made using a transmission electron microscope (TEM). Peri-implant osteoblastic activity was evaluated using samples obtained 5, 7, and 10 days after implant placement. Immunohistochemical evaluation of type I collagen, osteopontin, and osteocalcin was performed. Uniform smoothness of experimental implant surfaces was confirmed by scanning electron microscope(SEM) images. In the calcium phosphate layer, the compositional ratio of the experimental implant surface was Ca:P:O=1.0:0.79:2.8 based on the results of X-ray photoelectron spectroscopy(XPS). In the trabecular bone region, the BIC ratio was significantly higher in the experimental group than in the control group at 5, 7, 10, and 28 days after implant placement. Type I collagen, osteopontin, and osteocalcin immunostaining revealed that the experimental group tended to show positive results earlier than the control group. The results of this study suggest that surface treatment using a hydroxyapatite target and RF magnetron sputtering can enhance new bone formation during implant osseointegration.
Introduction
Dental implants have been used widely in clinical practice. Implant therapy has produced highly predictable results and is often considered the first-choice prosthesis to replace missing teeth 1, 2) . Dental implants are based on successful osseointegration, bonding between bone and implant surface. Modifications of implant surface have been studied for many years to improve the success and speed of reliable osseointegration [3] [4] [5] [6] . In many studies, the use of rough surfaced implants with Sa of approximately 2 mm was shown to increase the success of osseointegration and to yield good clinical results [7] [8] [9] [10] . These implants were prepared by blasting or acid etching. Another modification involves coating the implant surface with substances that promote regeneration of bone.
A typical example of this type of implant is the hydroxyapatitecoated implant 11) .
Hydroxyapatite (Ca 10 (PO 4 ) 6 (OH) 2 ) has been used widely as a biomaterial such as for implants and bone graft material because of its high osteoconductivity and biocompatibility 12, 13) . When compared with tissue and cells adjacent to titanium, those adjacent to hydroxyapatite have been shown to produce larger amounts of extracellular matrix components and proteins involved in bone formation 14, 15) . Hydroxyapatite coating on titanium surface promotes new bone formation at the implant-bone interface and accelerates osseointegration [16] [17] [18] . However, disadvantages of these implants are always concerning, including detachment and bioresorption of the coating film and rapid progress of inflammatory symptoms 19) . There have been efforts to address these concerns by improving the crystallization ratio of the coated hydroxyapatite and by strengthening the bond between titanium and hydroxyapatite 20, 21) . Studies have also been conducted using a thin coating layer of 1-5 m with the premise that there may be hydroxyapatite bioresorption and disappearance during or after achievement of osseointegration [22] [23] [24] . Thin hydroxyapatite coating has been shown to promote regeneration of bone on the implant surface, to enhance osseointegration, to be bioresorbed during osseointegration, and to establish stable osseointegration due to subsequent bonding of titanium and bone. However, only a small number of reports have involved study of coating thickness that effectively achieves osseointegration, and such thickness has not yet been established 25, 26) . In this study, thin coating was examined by developing experimental titanium implan ts sputter-coated from a hydroxyapatite target and by evaluating peri-implant tissue response in an animal experiment.
Materials and Methods

Experimental Implants
The experimental implants were prepared from plastic rods, each of which was 1.6 mm in diameter and 7.0 mm in length. The rods were coated with a thin titanium film, and the surfaces of the rods were sputter-coated from a hydroxyapatite target.
Thin titanium coating was deposited onto the rods using the method of Watazu reported by Okamatsu et al. 27) and Morinaga et al. 28) . Briefly, thin titanium coating of approximately 100 nm was deposited by a DC/RF sputtering system (L332S-FHS, Anelva, Tokyo, Japan) with a titanium target (99.9% purity, Kojundo Chemical Lab. Co. Ltd., Saitama, Japan) in a 2.2×10 -1 Pa argon atmosphere [27] [28] [29] [30] . Ti-coated implants were exposed to air. Subsequently RF magnetron sputtering was performed for 10 minutes using a Ca 10 (PO 4 ) 6 (OH) 2 target (HA, Kojundo Chemical Lab. Co. Ltd., Saitama, Japan) in a 0.6 Pa argon atmosphere ( Figure 1 ) ( Table 1 ). The controls were plastic implants coated with a thin titanium film. The coating characteristics were examined by placing plastic rods and microscope glass slides into a sputtering system, depositing titanium on their surfaces, and analyzing the surface composition by X-ray photoelectron spectroscopy (XPS, ESCALAB220iXL, VG Scientific Ltd., West Sussex, GBR). Surface morphology of the experimental implants was examined using scanning electron microscopy (SEM, S3500N, Hitachi Ltd., Tokyo, Japan).
Surgical Procedure
Thirty-six 8-week-old male SD rats were used. The rats were placed under isoflurane (Forane, Abbott Japan, Tokyo, Japan) inhalation anesthesia. The areas surrounding the bilateral knees were shaved and infiltration anesthesia was performed. An incision line was placed along the anterior border of each tibia, and the tibial bone surface was exposed. An implant socket with 1.6mm in diameter was prepared 10 mm distal to the knee joint, penetrating the bone medially and laterally. The experimental implant (titanium+hydroxyapatite) was placed in the right tibia, and these tibiae were established as the experimental group. A similar method was used to place the Ti-coated implant (titanium) in the left tibia as a control, and these tibiae were established as the control group. After implant placement, the muscular layer and skin layer were repositioned and sutured using absorbable suture, and the surgical procedure was completed. Postoperatively, the antibiotic Viccillin (Meiji Seika Pharma Co. Ltd., Tokyo, Japan) was administered intraperitoneally for prevention of infection.
This experiment was conducted with the approval of the Animal Experimentation Committee of Fukuoka Dental College (#11014).
Observation with a Light Microscope and Transmission Electron Microscope
The rats were placed under general anesthesia and perfusedfixed with half-strength Karnovsky's fixative at 3, 5, 7, 10, 14, and 28 days after implant placement. Samples were collected, immersed in fixative for 24 hours, and decalcified in 10% EDTA for 4 weeks. Subsequently, the samples were dehydrated in increasing ethanol series. They were embedded in resin (LR White interface in the posteromedial tibia where there is no muscle attachment and which is less susceptible to external stress ( Figure 2 ).
Semi-thin sections for light microscopy were obtained by cutting samples into approximately 0.7 μm thickness using a microtome (Reichert-Nissei Ultracut S, Leica, Wetzlar, Germany). Two sections (control and experimental) were obtained from each animal. Totally 5 sections were prepared on each time point. Subsequently the sections were stained with toluidine blue.
Ultrathin sections for transmission electron microscopy (approximately 70 nm thickness) were double stained with uranyl acetate and lead citrate.
Bone-Implant Contact Ratio (BIC)
The effects of sputtering surface treatment were examined by measuring the bone-implant contact ratios (BICs) of the samples for light microscopy. Measurement was made using a digital microscope (VHX-100, Keyence, Osaka, Japan). In the area of observation, the following measurements were made separately in the cortical bone and in the trabecular bone: the contact ratio of existing bone and implant per implant length and the contact ratio of new bone and implant per implant length. The Student t-test was used for statistical analysis for each time point.
Microstructure of bone was observed in the surroundings of each experimental implant. Observation of the implant-bone interface was made using a transmission electron microscope (1200-EX, JEOL Ltd., Tokyo, Japan).
Immunohistological Staining
Implants were placed using the same surgical procedure as described earlier. The rats were perfused-fixed with 10% neutral buffered formalin at 5, 7, and 10 days after implant placement. Immersion fixation was performed for 24 h ours, and decalcification was performed using K-CX (Falma, Tokyo, Japan) for 24 hours. The samples were embedded in paraffin and sliced into 3 m thickness sections using a microtome (SM2000R, Leica, Wetzlar, Germany). Two sections (control and experimental) were obtained from each animal. Totally 2 sections were prepared on each time point. The sections were deparaffinized and rinsed in water. Antigen retrieval was performed using 0.1% trypsin ( The sections were rinsed in PBS, developed in diaminobenzidine, rinsed, and stained with hemataoxylin. Subsequently they were rinsed, dehydrated, cleared, and coverslipped. Figure 3 shows the SEM image of the experimental implant.
Results
Experimental Implants
The surface of the experimental implant was uniformly smooth. The XPS analysis showed that the compositional ratio in the Figure 11 . TEM image 7 days after implant placement in the experimental group. Inclusion of osteocytes was seen in the n ew bone at the implant interface, and the osteocytes extended their processes. Bar = 2 m Figure 12 . TEM image 14 days after implant placement in the experimental group. Dense new bone formation was observed. Bar = 1 m Figure 13 . BIC ratio in the cortical bone region (n = 5).
There was no statistically significant difference in BIC ratio between the experimental group and the control group at all time points. Figure 14 . BIC ratio in the trabecular bone region (n = 5). The experimental group had a significantly higher BIC ratio than the control group at 5, 7, 10, and 28 days after implant placement (*p<0.05).
calcium phosphate layer was Ca: P: O = 1.0: 0.79: 2.8 ( Figure 4 ).
Observation with a Light Microscope
Three days after implant placement: In the cortical bone region in the experimental group and control group, some areas of implant surface were in contact with the existing cortical bone, and aggregation of red blood cells and inflammatory cells was observed. Lacunae without osteocytes were observed near the implants. In the bone marrow region in both groups, small bone fragments and red blood cells were observed which were thought to have migrated into the bone marrow when implant socket were prepared, and inflammatory cells were seen in some areas. For both groups, flat cells were observed on the implant surface. In the experimental group, some areas of the implant interface were lined with osteoblast-like cells ( Figure 5 ).
Five days after implant placement: In the cortical bone region in both groups, red blood cells and inflammatory cells were scarce between the implant and cortical bone. However, osteoblast-like cells were observed. In the bone marrow region, fibrous calluslike tissue was observed in more extensive areas of the implant surface in the experimental group than in the control group ( Figure   6 ). Fibrous osteoid tissue had formed which connected small bone fragments or the existing bones. The osteoid tissue was surrounded by osteoblast-like tissue. Many plasmacytoid cells were seen in the experimental group.
Seven days after implant placement: In the experimental group, callus-like tissue was observed in extensive areas of the implant surface. Similar tissue was seen in the control group but was immature and fragmented. There was more continuity in the tissue in the experimental group. In the experimental group, there was development of cellular osteoid tissue, which was prominent in the bone marrow region near the cortical bone ( Figure 7) .
Ten days after implant placement: In the cortical region in both groups, contact between the implant surface and bony tissue was observed in extensive areas. In the bone marrow region, there was more continuity of newly formed bone in the experimental group than in the control group (Figure 8 ). In the experimental group, inclusion of osteocytes in the bone matrix was more frequently seen and the bone matrix was thicker.
Fourteen days after implant placement: In the cortical bone region in both groups, new bone formation was observed that progressed from the side of the cortical bone. Osteoblast-like cells lined the gap between the implant and cortical bone. In the bone marrow region, thicker and denser new bone had formed in the experimental group compared with the control group ( Figure 9 ). Twenty-eight days after implant placement: In the cortical bone region in both groups, dense bony tissue was in contact with the implant. In the bone marrow region, more extensive and denser new bone had formed on the implant surface in the experimental group compared with the control group (Figure 10 ).
Observation with a Transmission Electron Microscope
Seven days after implant placement: In the TEM images ofthe experimental group, new bone was observed in the implant interfaces. Inclusion of osteocytes was seen in the bone matrix, and the osteocyte processes were extending toward the implant surface. Collagen-like tissue was in the surroundings ( Figure 11 ).
Fourteen days after implant placement: Dense new bone had formed at the implant interface in the experimental group. That is, an amorphous layer was observed (Figure 12 ). Figures 13 and 14 show the BIC ratios in the cortical bone region and bone marrow region at each time point. Three days after implant placement: In the cortical bone, the BIC ratio was 49.75% and 53.45% in the control group and experimental group, respectively. In the trabecular bone region, it was 40.22% and 47.07%, respectively. In each region, there was no statistically significant difference in the BIC ratio between the experimental group and control group. Five days after implant placement: In the cortical bone, the BIC ratio was 61.50% and 74.97%, respectively, indicating no statistically significant difference. In the trabecular bone region, it was 60.74% and 84.31%, respectively, indicating a significantly greater BIC ratio in the experimental group.
Bone-Implant Contact Ratio (BIC)
Seven days after implant placement: In the cortical bone, the BIC ratio was 66.68% and 81.05%, respectively, indicating no statistically significant difference. In the trabecular bone region, it was 69.63% and 84.72%, respectively, indicating a significantly greater BIC ratio in the experimental group.
Ten days after implant placement: In the cortical bone, the BIC ratio was 72.16% and 86.6%, respectively, indicating no statistically significant difference. In the trabecular bone region, it was 78.88% and 92.51%, respectively, indicating a significantly greater BIC ratio in the experimental group.
Fourteen days after implant placement: In the cortical bone, the BIC ratio was 69.24% and 79.79%, respectively. In the trabecular bone region, it was 79.44% and 76.26%, respectively.
These results showed no significant difference in BIC ratio in between the two groups.
Twenty-eight days after implant placement in the cortical bone, the BIC ratio was 81.65% and 94.85%, respectively, indicating no statistically significant difference. In the trabecular bone region, it was 86.09% and 96.00%, respectively, indicating a significantly greater BIC ratio in the experimental group.
Immunohistological Staining Type I Collagen
Five days after implant placement: In both experimental and control groups, staining was positive for type I collagen at the existing bone-implant contact interface. In the control group, the positively stained osteoblast-like cells were lined between the existing bones. In the experimental group, formation of positively stained new bone progressed between existing bones along the implant surface (Figure 15 ). In addition, there was a network of positively stained osteoblast-like cells.
Seven days after implant placement: In the experimental group, positively stained new osteoid tissue was observed at the implant interface. In the control group, positive staining was also seen in many areas at the implant interface. The experimental group showed positively stained new bone that connected the existing bones in many areas. The osteoblast-like cells lined the bone marrow side of the new bone. In addition, positively stained osteoblast-like cells were observed in the gap between the implant and bone in the experimental group.
Ten days after implant placement: Both experimental and control groups showed extensive positively stained areas. In the experimental group, positively stained areas were seen between the new bone at the implant interface and the surrounding existing bone.
Osteopontin
Five days after implant placement: In the experimental group, positively stained areas were seen at the implant interface. However, new osteoid tissue with a clear cement line was rarely seen. In the control group, positively stained areas were scarce at the implant interface.
Seven days after implant placement: In the experimental group, positively stained osteoblast-like cells aggregated at the implant interface, and there was fine new bone with a positively stained cement line (Figure 16 ). In addition, positively stained osteoblastlike cells were seen between the new bone at the implant interface and the existing bone on the bone marrow side of the new bone. The experimental group had more extensive positively stained areas compared with the control group.
Ten days after implant placement: In the cortical bone in the experimental group, new bone had filled the gap at the implant interface between the existing bones, and a positively stained cement line was observed. In the trabecular bone region, the formation of new bone progressed from bone to bone along the implant interface. Inclusion of positively stained osteoblast-like cells was seen in the bone matrix. In addition, a positively stained cement line was seen which connected bone fragments at the implant interface. In the control group, similar findings were observed in some areas. However, the control group had a wider gap between the existing bones and fewer positively stained areas compared with the experimental group.
Osteocalcin
Five days after implant placement: Both experimental and control groups showed positively stained cells in the existing bone. In the experimental implant group, positively stained cells were observed in the stratified new bone at the implant interface.
Positively stained osteoblasts lined the bone marrow side of the new bone.
Seven days after implant placement: In the experimental group, positively stained osteoblasts and inclusion of positive cells in the new bone were observed in extensive areas at the implant interface ( Figure 17 ). In addition, many positively stained osteoblasts were seen in the gap between the existing bone and implant. In the control group, positive cells increased but not to the extent as in the experimental group.
Ten days after implant placement: In the experimental group, positively stained cells were observed in extensive areas, just as at 7 days after placement. A line of positively stained osteoblasts was seen that connected the bony tissues.
Discussion Calcium phosphate, a component in hydroxyapatite, has high osteoconductivity and biocompatibility. Therefore, hydroxyapatite has been used widely as a biomaterial such as for implants and bone graft material [31] [32] [33] . When compared with tissue and cells adjacent to titanium, those adjacent to hydroxyapatite have been shown to produce larger amounts of extracellular matrix components and proteins involved in bone formation 34, 35) . There is an amorphous layer of approximately 50 nm in the bond between titanium and bone (i.e., the interface of osseointegration) 36, 37) .
Bagambisa et al. observed a direct bond between hydroxyapatite and bone, i.e., direct bond in biointegration 38) .
Since hydroxyapatite is not a strong material, it cannot be used as a dental implant material. However, it can be applied to a titanium surface to promote bone formation at the implant-bone interface and to accelerate osseointegration 39) . In 1982, implants were made commercially available which were plasma sprayed with a hydroxyapatite coating. Since then, many of these implants have been used in clinical practice. They have been placed in patients with unfavorable conditions, such as those with poor bone quality, and have yielded good results [40] [41] [42] . Truhlar et al. examined HA-coated implants and non-coated implants. They found that the coated implants had significantly higher 3-year survival rates in areas with poor bone quality of type 3 or 4 compared with noncoated implants 43) . However, Albrektsson et al. indicated early the disadvantages such as detachment and bioresorption of the coating film and fast progress of inflammatory symptoms 44) . These concerns have not been fully addressed to date. Schwartz-Arad et al. conducted a 12-year follow-up study. They found that the survival rate of the hydroxyapatite-coated implants rapidly decreased beyond 4 years compared with that of the titanium implants. Beyond 5 years after superstructure placement, the failures were mostly in hydroxyapatite-coated implants 45) .
When hydroxyapatite is coated to approximately 1-5 m thickness by sputtering or thermal decomposition, the premise is that hydroxyapatite might gradually be bioresorbed and disappear.
Titanium-bone osseointegration under the hydroxyapatite coating can be accelerated depending on the thickness of the coating 46, 47) .
Osseointegration initially involves a bond between hydroxyapatite and bone, which finally changes to a bond between titanium and bone 48) . Implants have been coated with hydroxyapatite of 1-3 m thickness by sputtering or thermal decomposition. These implants have already been applied to clinical practice. Hayakawa et al.
used the RF magnetron sputtering technique to coat titanium implants with a thin film of 2-4 m hydroxyapatite. They placed these implants in rabbits and evaluated histologically and histomorphometrically. They found that the coating had a beneficial effect on the bone response to the healing phase at an early stage after implant placement 47) . Ong et al. used the sputtering method to coat hydroxyapatite with thicknesses of 1.4 m onto implants. They performed a pull-out test and found high osteoconductivity at an early stage. The pull-out strength showed similar strength in comparison with the plasma-splayed method 49) .
The results of these reports suggest that high osseointegration strength can be achieved early due to the effects of hydroxyapatite with a few micrometer thickness. Ozeki et al. compared plasmasprayed coating and sputtered film of hydroxyapatite and found that the latter had higher bone bonding strength 50) . In our study, the experimental implants were titanium implants sputter-coated from a hydroxyapatite target using an RF magnetron sputtering system. XPS analysis confirmed the presence of Ca-P deposited by sputtering. However, the presence could not be confirmed by TEM because of the extremely small quantities 51) . Therefore, it was thought that hydroxyapatite was bioresorbed and disappeared during osseointegration, and that osseointegration between titanium and bone was rapidly achieved.
Our histological evaluation showed that the hydroxyapatitecoated implants showed earlier new bone formation near the implant surface compared with the titanium implants. The amount of bone contacting the implant surface was evaluated as BIC. In the trabecular bone region, the BIC ration of the experimental implants was significantly higher than that of the control titanium implants at 5, 7, and 10, and 28 days after implant placement. In another study, titanium-coated implants were placed in rat tibia, and the microstructure of peri-implant tissue was examined over time. There was maturation of osseointegration at 28 days after implant placement 28) . In our present study, the results suggest that the experimental implant surface showed more enhanced osseointegration than the titanium implant surface, mainly in the trabecular bone region from early after implant placement until completion of osseointegration.
The results of type I collagen immunostaining showed positively stained cells that were orderly arranged in the bone surrounding experimental implant and the surrounding trabecular bone. Immature osteoid tissue was also seen. Osteopontin is a marker of osteoblast differentiation. Osteopontin immunostaining was strongly positive at the boundary of the experimental implant surface with the existing bone and with new bone. Osteocalcin is a marker for bone formation. In osteocalcin immunostaining, strongly positive staining was seen of osteoblasts which were orderly arranged on the trabecular bone surface on the side of the bone marrow in the experimental implant surroundings. These immunostaining results suggest that new bone was formed by osteoblasts in the experimental implant surroundings and that there was a high level of maturity of bone and osteoblasts. These results were consistent with the BIC ratio measurements.
The results of our experiment showed that the use of titanium implants sputter-coated from a hydroxyapatite target can shorten the time to achieve osseointegration, and that the area of new bone formation increased in the trabecular bone region. Since this surface treatment does not greatly change the texture of the titanium implant surface, it differs from the method in which there is adhesion of a Ca-P film onto the implant surface. Therefore, the bond between titanium and bone is thought to be achieved smoothly. The results of our experiment suggest that this new surface treatment attains both early osseointegration and maintenance of stable osseointegration.
In this study, experimental implants were prepared by coating calcium phosphate derived from hydroxyapatite. The animal experiment was conducted by placing these implants in rat tibiae, and good osseointegration was obtained.
Light microscopy and immunostaining showed that new bone formation was promoted in tibiae with the experimental implants. In the trabecular region, the experimental group showed a significantly higher BIC ratio compared with the control group at 5, 7, 10, and 28 days after implant placement. Type I collagen, osteopontin, and osteocalcin immunostaining showed that the experimental group tended to show more positively stained areas earlier compared with the control group.
In our experiment, implants were sputter-coated from a hydroxyapatite target by an RF magnetron sputtering system. Our results suggest that these implants enhance new bone formation during implant osseointegration.
